Powered by

Evonetix Raises $12.3 Million USD (£9 Million GBP) to Advance Development of Its Highly Novel Gene Synthesis Platform

Jan 30, 2018 - Business Wire

EVONETIX LTD ('Evonetix'), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has completed a $12.3 million (£9 million) financing to advance the development of its technology.

The financing was co-led by DCVC (Data Collective) of Palo Alto, CA and European-based Draper Esprit, and included the Morningside group, alongside existing investors Providence Investment Company (Jersey), Cambridge Consultants...